跳至主要内容
临床试验/JPRN-UMIN000009742
JPRN-UMIN000009742已完成2 期

A validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone. (AVOID) - A validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone. (AVOID)

Fukuoka University School of Medicine Department of Gastroenterological Surgery0 个研究点目标入组 70 人开始时间: 2013年1月10日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Prior severe drug allerg 2.Presence of active infection 3.Multiple malignancy within 5 years disease free interval 4.Uncontrolled hypertension or diabetes 5. Severe peripheral nerve disorder 6.Chronic systemic treatment of corticosteroid 7.Nursing or pregnant females, or females or males with female partners who are planning to pregnancy 8.Inadequate for study enrollment by the physician

研究者

发起方
Fukuoka University School of Medicine Department of Gastroenterological Surgery

相似试验

已完成
3 期
A randomized phase III study of oxaliplatin based chemotherapy versus combination chemotherapy of TS-1,irinotecan and bevacizumab as first line therapy for unresectable or recurrent colorectal cancer
JPRN-UMIN000007834The Tokyo Cooperative Oncology Group450
已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancer
JPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42
已完成
2 期
A phase II study of Oxaliplatin Reintroduction in patients pretreated with Oxaliplatin and Irinotecan for Advanced Colorectal CancerMetastatic colorectal cancer
JPRN-UMIN000004884Japanese foundation for cancer research33
已完成
1 期
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell LymphomaChildhood Grade III Lymphomatoid GranulomatosisChildhood Immunoblastic Large Cell LymphomaRecurrent Childhood Brain Stem GliomaRecurrent Childhood Cerebellar AstrocytomaRecurrent Childhood Cerebral AstrocytomaRecurrent Childhood EpendymomaRecurrent Childhood Grade III Lymphomatoid GranulomatosisRecurrent Childhood Large Cell LymphomaRecurrent Childhood Liver CancerRecurrent Childhood Lymphoblastic LymphomaRecurrent Childhood Malignant Germ Cell TumorRecurrent Childhood MedulloblastomaRecurrent Childhood RhabdomyosarcomaRecurrent Childhood Small Noncleaved Cell LymphomaRecurrent Childhood Soft Tissue SarcomaRecurrent Childhood Supratentorial Primitive Neuroectodermal TumorRecurrent Childhood Visual Pathway GliomaRecurrent Colon CancerRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent MelanomaRecurrent Nasopharyngeal CancerRecurrent NeuroblastomaRecurrent OsteosarcomaRecurrent Wilms Tumor and Other Childhood Kidney TumorsRecurrent/Refractory Childhood Hodgkin LymphomaUnspecified Childhood Solid Tumor, Protocol Specific
NCT00101270National Cancer Institute (NCI)24
终止
1 期
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung CancerCarcinoma, Non-Small Cell Lung
NCT00268151University of Louisville24